Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endostar and IMRT vs. IMRT Alone for Locally Recurrent Nasopharyngeal Carcinoma
NCT02636231Phase 2Unknown
- Sponsor
- Sun Yat-sen University
- Start
- Nov 2015
- Primary completion
- Mar 2020
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of endostar in nasopharyngeal carcinoma (NPC), sponsored by Sun Yat-sen University. Status: unknown.
02
Drugs
endostar
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT02636231.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02636231.